Bank of Montreal’s AbbVie ABBV Stock Holding History

Bank of Montreal’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29,000	Closed	-$4.75M	–	4042
2022 Q1	$4.75M	Buy	+29,000	New	+$4.21M	﹤0.01%	1524
2019 Q2	–	Sell	-15,000	Closed	-$1.21M	–	4830
2019 Q1	$1.21M	Buy	15,000 +10,000	+200%	+$818K	﹤0.01%	1949
2018 Q4	$461K	Buy	+5,000	New	+$440K	﹤0.01%	2205

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of Montreal's ABBV Position: Q2 2026 in Review

Bank of Montreal increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $84.2M and bringing the position to 3,470,007 shares worth $873M. The position accounts for 0.29% of the portfolio, ranked #74.

Bank of Montreal first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bank of Montreal held 3,470,007 shares of AbbVie worth $873M as of Q2 2026.
Bank of Montreal bought 391,512 AbbVie shares in Q2 2026, an estimated $84.2M.
AbbVie made up 0.29% of Bank of Montreal's portfolio in Q2 2026, its #74 holding.
Bank of Montreal first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.